Clinical and Actigraphic Profile of Young Patients Admitted for Attempted Suicide

Suicide, Attempted Clinical Trial

— ACTIHUMEUR  

Official title:

Clinical and Actigraphic Profile of Young Patients Admitted for Attempted Suicide: Investigation of Disruptive Mood Dysregulation Disorder

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02803632
• Other study ID #: AOL11-DR -GUILE
• Status: Terminated
• Phase: N/A
• Start date: February 6, 2013
• Est. completion date: August 24, 2018

Study information

• Verified date: December 2020
• Source: Centre Hospitalier Universitaire, Amiens
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

An excess suicide-related morbidity is observed among young people in the Picardie region, as reflected by the > 100% occupation rate of the Amiens University Hospital Adolescent Medicine Unit

Description:

An excess suicide-related morbidity is observed among young people in the Picardie region, as reflected by the > 100% occupation rate of the Amiens University Hospital Adolescent Medicine Unit. New approaches have been proposed to these problems that have led us to reorganize our diagnostic practices: 1) more precise characterization of suicidal behaviour by using standardized instruments such as the French version of the Columbia-Suicide Severity Rating Scale developed by Posner (C-SSRS); 2) new clinical entities, such as disruptive mood dysregulation disorder, are now proposed in international classifications (DSM 5 field trial); 3) investigations such as recording of the circadian rhythm of motor activity by actigraphy are being studied as a laboratory complement to psychiatric diagnosis.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 98
• Est. completion date: August 24, 2018
• Est. primary completion date: August 24, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 6 Years to 17 Years

Eligibility

Inclusion Criteria:

• children/adolescents admitted after a suicide attempt

Exclusion Criteria:

• severe depression

• mental retardation

• pervasive developmental disorder

• active psychotic episode,

• drug and alcohol abuse at the time of admission

• organic sleep-wake disorders (sleep-related respiratory and motor disorders, narcolepsy)

• any contraindication formulated by the clinical team

• patients not covered by French national health insurance, patients deprived of their freedom as stipulated in Article L.1121-6 of the French Public Health Code

Related Conditions & MeSH terms

• Suicide
• Suicide, Attempted

Intervention

Behavioral:
• questionnaires

Device:
• actigraphic recording

Locations

Country	Name	City	State
France	CHU Amiens	Amiens
France	AP HP	Paris

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire, Amiens

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The variable absence / presence of the disruptive mood dysregulation disorder (DMDD)	The variable absence / presence of the disruptive mood dysregulation disorder (DMDD)	Day 0